CMPB Central Pathology Support
CMPB 中央病理学支持
基本信息
- 批准号:9143533
- 负责人:
- 金额:$ 1297.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AnatomyAtherosclerosisAutopsyBiological AssayBloodBody FluidsCardiovascular DiseasesCellsChronicClinicalClinical PathologyCollaborationsCommunitiesConsultationsDevelopmentDiseaseElectron MicroscopyGene ExpressionGene Expression RegulationGoalsHistologyImmuneImmunohistochemistryInflammatoryInstitutesKidney DiseasesLaboratoriesLaboratory AnimalsLaboratory ResearchLasersLesionLung diseasesMalignant NeoplasmsMediatingMedical ResearchMethodsMicrodissectionMolecularMusNational Institute of Environmental Health SciencesNon-Insulin-Dependent Diabetes MellitusObesityPathogenesisPathologistPathologyPhenotypeProcessProtocols documentationResearchResearch PersonnelRetrospective StudiesServicesSkeletal DevelopmentTechnical ExpertiseTechniquesTestingWorkanimal tissuebasedietary restrictiondigital imagingneoplasticnew technologyprogramssample collection
项目摘要
The CMPB Pathology Core Laboratories have continued to provide critical pathology support services, collaboration and consultation for over 60 research laboratories across the Institute. Over the past year, collaborative and support oriented work has had a significant impact on a spectrum of research programs involved in the study and understanding of a variety of diseases and disease processes such as cardiovascular disease (atherosclerosis), inflammatory respiratory disease, obesity and type II diabetes, inflammatory and immune-mediated renal disease, gene expression and gene regulation, axial skeletal development, cancer and transgenerational effects of diet restriction. The volume and scope of work has increased significantly across all of the Core Laboratories, as have collaborations and consultations with scientific staff whether on a technical level regarding the methods required, or on a scientific level, requiring consultation with a staff pathologist. Core staff have worked with investigators to develop and establish specialized techniques and protocols for a variety of applications. Additionally, using materials from the DNTP subchronic (90-day) and chronic (2-year) bioassays, the Cores have been involved in retrospective studies aimed at elucidating the pathogenesis and molecular mechanisms involved in the development of variety of proliferative non-neoplastic neoplastic lesions.
CMPB病理学核心实验室继续为研究所内的60多个研究实验室提供关键病理支持服务、协作和咨询。在过去的一年里,以协作和支持为导向的工作对一系列研究项目产生了重大影响,这些项目涉及研究和了解各种疾病和疾病过程,如心血管疾病(动脉粥样硬化)、炎症性呼吸系统疾病、肥胖症和II型糖尿病、炎症和免疫介导的肾脏疾病、基因表达和基因调控、中轴骨骼发育、癌症和饮食限制的跨代影响。所有核心实验室的工作量和工作范围都大大增加,与科学工作人员的合作和磋商也大大增加,无论是在所需方法的技术层面上,还是在科学层面上,需要与工作人员病理学家进行磋商。核心工作人员与调查人员合作,为各种应用开发和建立专门的技术和协议。此外,使用dNTP亚慢性(90天)和慢性(2年)生物测定的材料,这些核心已经参与了旨在阐明各种增殖性非肿瘤性肿瘤病变的发病机制和分子机制的回顾性研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Sills其他文献
Robert Sills的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Sills', 18)}}的其他基金
Clean Air Act Neurotoxicity Studies and NTP/NIEHS Neuropathology Evaluations
《清洁空气法》神经毒性研究和 NTP/NIEHS 神经病理学评估
- 批准号:
7967965 - 财政年份:
- 资助金额:
$ 1297.31万 - 项目类别:
Clean Air Act Neurotoxicity Studies and NTP/NIEHS Neuropathology Evaluations
《清洁空气法》神经毒性研究和 NTP/NIEHS 神经病理学评估
- 批准号:
8734053 - 财政年份:
- 资助金额:
$ 1297.31万 - 项目类别:
Clean Air Act Neurotoxicity Studies and NTP/NIEHS Neuropathology Evaluations
《清洁空气法》神经毒性研究和 NTP/NIEHS 神经病理学评估
- 批准号:
8148986 - 财政年份:
- 资助金额:
$ 1297.31万 - 项目类别:
Clean Air Act Neurotoxicity Studies and NTP/NIEHS Neuropathology Evaluations
《清洁空气法》神经毒性研究和 NTP/NIEHS 神经病理学评估
- 批准号:
8553680 - 财政年份:
- 资助金额:
$ 1297.31万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 1297.31万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 1297.31万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 1297.31万 - 项目类别:
Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 1297.31万 - 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 1297.31万 - 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
- 批准号:
10589484 - 财政年份:2023
- 资助金额:
$ 1297.31万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 1297.31万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 1297.31万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 1297.31万 - 项目类别: